The new ImpactAir-ISO-90 and ImpactAir-90 ranges are designed for use in high-grade areas within the pharmaceutical, healthcare, and specialist food industries where process monitoring of viable particles is necessary.
Cherwell introduced new models to its ImpactAir range of microbial air monitors distributed from Pinpoint Scientific.
The new ImpactAir-ISO-90 and ImpactAir-90 ranges are designed for use in high-grade areas within the pharmaceutical industry as well as other industries (e.g., healthcare, specialist food industries) where process monitoring of viable particles is necessary. Both ranges are equipped with a chamber for a 90-mm petri dish and use a slit-to-agar method that ensures particles, including microbes, impact the petri dish’s agar surface. As the dish rotates under the inlet, air is impacted onto an area of agar, reducing twin impingement risk and microbe desiccation for a high biological and physical efficiency.
Additionally, each range includes an ISO-90 Monitoring Head that contains all the controls needed to rotate the agar plate during the monitoring phase.
Individually, the ISO-90 range consists of:
The ImpactAir-90 range includes:
“We are really excited by the opportunities that the new range of air monitors from Pinpoint offer,” said Andy Whittard, managing director at Cherwell, in an April 21, 2021 press release. “The compact, 90-mm Petri version slit-to-agar range can help users address the challenges presented by the new Annex 1 and the focus on continuous monitoring. The various options also provide users with differing solutions for challenges within their facilities.”
Source: Cherwell
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.